Alzheimer's Disease (AD) is a common, progressive, dementing disorder that is devastating to the patient and family. Memory loss is often its earliest and most prominent symptom. The memory loss may be due, in part, to the hippocampal cell less observed in AD. The cause of cell death is unclear, but an important clue may come from the observation that amyloid is deposited in the disorder. While the reasons for amyloid deposition and its effects on neurons are still debated, many studies support the hypothesis that amyloid is toxic to neurons. The mechanism by which amyloid may exert a toxic effect is unknown. Several lines of evidence, however, suggest that it may affect neuronal calcium homeostasis. In addition, several other factors may affect intracellular calcium in aged, adult hippocampal neurons including altered calcium binding proteins, increased calcium influx through NMDA receptors, and the normal activation of memory processes in hippocampus that require large calcium influxes. In combination with these three factors, amyloid may raise intracellular calcium levels across the threshold for calcium- mediated, excitotoxic cell death. The mechanism by which amyloid might raise intracellular calcium is unknown.
Specific Aims 1 and 2 are to test the hypotheses that amyloid increases calcium influx through voltage-dependent calcium channels and/or NMDA receptors. Currents will be measured using the blind, whole-cell, patch-clamp recording technique in the hippocampal slice preparation. Calcium influx will be compared between neurons in which the recording electrode contains vehicle or scrambled beta1-42 and ones which contain beta1-42. An adult preparation will be used and the slices will be obtained acutely in order to replicate some of the conditions present in AD. Understanding the mechanism of amyloid toxicity might help in designing treatments that prevent progression of Alzheimer;s disease. It may also help explain why memory and the hippocampus are so prominently involved in AD. It is anticipated what the results of this pilot project will be the basis for a subsequent full-length proposal further examining the mechanisms of amyloid-mediated cell death and how the three other factors noted above may contribute to that cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG008664-09S4
Application #
6218716
Study Section
Project Start
1999-08-15
Project End
2003-05-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Doody, R; Pavlik, V; Massman, Paul et al. (2005) Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord 20:198-208
Waring, Stephen C; Doody, Rachelle S; Pavlik, Valory N et al. (2005) Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 19:178-83
Hoyt, Brian D; Massman, Paul J; Schatschneider, Christopher et al. (2005) Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 62:454-9
Snow, A Lynn; Norris, Margaret P; Doody, Rachelle et al. (2004) Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord 18:22-31
Doody, Rachelle Smith; Dunn, J Kay; Huang, Eugene et al. (2004) A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord 17:1-4
Atchison, Timothy B; Bradshaw, Major; Massman, Paul J (2004) Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data. Arch Clin Neuropsychol 19:1007-15
Graham, David P; Cully, Jeffrey A; Snow, A Lynn et al. (2004) The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 18:236-40
Clark, Christopher M; Xie, Sharon; Chittams, Jesse et al. (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60:1696-702
Davis, Robert N; Massman, Paul J; Doody, Rachelle S (2003) WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability. Psychol Aging 18:836-43
Davis, Robert N; Massman, Paul J; Doody, Rachelle S (2003) Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol 18:19-32

Showing the most recent 10 out of 48 publications